1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 21,600 | 22,600 | 09:58 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.08. | Getinge's NAVA technology featured on national television | 3 | Cision News | ||
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 17.07. | Getinge Q2 2026 slides: margin expansion, strong cash flow drive rally | 2 | Investing.com | ||
| 17.07. | Getinge AB Q2 Income Rises | 3 | RTTNews | ||
| 17.07. | Getinge AB (publ) reports Q2 results | 11 | Seeking Alpha | ||
| 17.07. | Getinge Aktie legt nach starkem Q2 dank Zollerstattungen und Preiserhöhungen kräftig zu | 5 | Investing.com Deutsch | ||
| 17.07. | Getinge AB: Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow | 251 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on July 17, 2026
"We delivered a strong quarter both financially and operationally with several important key achievements", says Mattias Perjos, President and CEO... ► Artikel lesen | |
| 09.07. | Getinge zieht als neuer Mieter ins HEADS Office bei München | 2 | DEAL-Magazin | ||
| 07.07. | Getinge supports neonatal critical care training in India | 1 | Cision News | ||
| 03.07. | Getinge receives refund of tariffs paid under IEEPA | 2 | Cision News | ||
| 03.07. | Getinge invites fund managers, analysts, and media to Q2 Report 2026 conference call | 1 | Cision News | ||
| 26.06. | Getinge opens digital OR hub in Germany | - | MassDevice | ||
| 26.06. | New hub accelerates Getinge's digital healthcare innovation | 2 | Cision News | ||
| 18.06. | Getinge launches Fluobeam LS, advancing fluorescence imaging for small-incision procedures | 2 | Cision News | ||
| 11.06. | Getinge elevates automated endoscope reprocessing with Aquadis Endo 110 | 2 | Cision News | ||
| 02.06. | Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting | 2 | Cision News | ||
| 28.05. | Massachusetts court sides with Abiomed in Getinge patent spat | 5 | MassDevice | ||
| 28.05. | Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S. | 2 | Cision News | ||
| 27.04. | Getinge boosts GSS67N sterilizer throughput with expanded validated load capacity at HSPA 2026 | 10 | Cision News | ||
| 21.04. | Getinge AB: Resolutions at Getinge's Annual General Meeting April 21, 2026 | 414 | GlobeNewswire (Europe) | Press Release
Gothenburg, Sweden on April 21, 2026
Getinge AB (publ)'s Annual General Meeting ("AGM") was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the... ► Artikel lesen | |
| 21.04. | Getinge AB Non-GAAP EPS of SEK 1.80; maintains FY26 forecast of organic sales growth | 5 | Seeking Alpha |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,920 | -0,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ESSILORLUXOTTICA | 161,30 | +0,12 % | Vom Patent zum Patienten: Wie Rise Nano Optics jetzt in den Milliardenmarkt für Augengesundheit einsteigen will | ||
| ALIGN TECHNOLOGY | 136,50 | +0,37 % | Align Technology Wins China Patent Case Against Angelalign | WASHINGTON (dpa-AFX) - Align Technology, Inc. (ALGN), said the Jinan Intermediate People's Court in China ruled in its favor in a patent infringement case against Angelalign Technology's Chinese... ► Artikel lesen | |
| INMODE | 12,800 | -0,16 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| ELEVANCE HEALTH | 344,30 | +1,12 % | Elevance Health Raises FY26 Guidance; Expects To Return To At Least 12% Adj. EPS Growth In 2027 | WASHINGTON (dpa-AFX) - Elevance Health (ELV) said second quarter results exceeded its outlook. The company increased 2026 EPS guidance to at least $20.10, and lifted 2026 adjusted EPS guidance... ► Artikel lesen | |
| BONESUPPORT | 20,540 | +0,20 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| TENET | 232,00 | +0,87 % | If You Invested $100 In Tenet Healthcare Stock 10 Years Ago, You Would Have This Much Today | ||
| ARJO | 2,528 | +0,32 % | Arjo AB: Arjo's interim report January-June 2026 | "We grew by 4.7% organically in the quarter, driven by high demand for our products and solutions. We are also now taking important steps to enhance our focus, efficiency, and profitability - and to... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 30,000 | 0,00 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Second Quarter 2026 Results | Quarterly revenue of $673 million and adjusted EBITDA of $73 million;
GAAP income of $0.53/share and adjusted EPS of $0.77
DALLAS, Aug. 6, 2026 /PRNewswire/ --... ► Artikel lesen | |
| ALPHATEC | 7,900 | +1,28 % | Alphatec signals $140M adjusted EBITDA guidance for 2026 while maintaining ~$882M revenue outlook | ||
| FISHER & PAYKEL HEALTHCARE | 22,000 | 0,00 % | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: 2026 Annual Shareholders Meeting Results | ||
| OSSDSIGN | 0,333 | -1,62 % | OssDsign AB: OssDsign AB (publ) publishes Q2 2026 interim report | Progress: Building the foundation for OssDsign growth
OssDsign AB (publ) announces that the interim report for Q2 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A... ► Artikel lesen | |
| STEREOTAXIS | 1,262 | +1,12 % | Citizens lowers Stereotaxis stock price target to $3 on guidance cut | ||
| PENNANT GROUP | 31,800 | 0,00 % | Wells Fargo raises Pennant Group stock price target on earnings outlook |
Das Unternehmen GETINGE AB ADR kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 21,400 Euro und damit -0,93 % im Minus. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.